tiprankstipranks
Trending News
More News >
Hodogaya Chemical Co., Ltd. (JP:4112)
:4112
Japanese Market

Hodogaya Chemical Co., Ltd. (4112) AI Stock Analysis

Compare
0 Followers

Top Page

JP:4112

Hodogaya Chemical Co., Ltd.

(4112)

Select Model
Select Model
Select Model
Neutral 67 (OpenAI - 5.2)
Rating:67Neutral
Price Target:
¥2,592.00
▲(38.09% Upside)
Action:ReiteratedDate:02/18/26
The score is driven primarily by solid financial stability from low leverage and steady revenue, but it is capped by the recent profitability step-down and weak, volatile free cash flow. Technicals are supportive with an uptrend and positive momentum, while valuation looks reasonable with a mid-range P/E and moderate dividend yield.
Positive Factors
Low leverage / strong balance sheet
A low debt-to-equity (~0.18–0.21 historically; 0.19 TTM) and rising equity provide durable financial flexibility. This balance-sheet strength supports capital expenditure, cyclical resilience, targeted acquisitions, and ability to absorb industry downturns without forcing dilutive financing.
Diversified specialty-chemicals portfolio
Hodogaya’s exposure across pigments, electronic-materials, and other performance chemicals gives structurally diversified end markets. That product mix supports steady demand across cycles, reduces single-market concentration risk, and preserves long-term revenue stability as industrial and electronics demand evolves.
Stable, above-average gross margins
Sustained gross margins in the high 30s percent reflect differentiated specialty products and pricing leverage versus commodity peers. That margin base helps absorb input-cost volatility, underpins operating profit potential over time, and supports reinvestment in R&D and customer-facing capabilities.
Negative Factors
Profitability step-down
Recent margin compression and lower returns on equity indicate weakening earnings power versus prior years. Persistently lower operating and net margins reduce cash available for reinvestment and dividend support, pressuring medium-term returns and the company’s ability to finance growth organically.
Volatile and weak free cash flow
High variability in free cash flow driven by working-capital and investment swings weakens cash reliability. Weak FCF constrains capital allocation flexibility for capex, dividends or M&A, and increases the risk that management may need external financing during investment or cyclical downcycles.
Recent revenue and EPS deterioration
Material declines in reported revenue and EPS growth point to near-term demand softness or margin pressure that could persist. Continued top-line contraction and large EPS decline undermine scale economies and raise the bar for management to restore sustainable earnings growth over the next several quarters.

Hodogaya Chemical Co., Ltd. (4112) vs. iShares MSCI Japan ETF (EWJ)

Hodogaya Chemical Co., Ltd. Business Overview & Revenue Model

Company DescriptionHodogaya Chemical Co., Ltd. (4112) is a Japan-based company engaged in the development, manufacture, and sale of chemical products. The company operates primarily in sectors such as specialty chemicals, fine chemicals, and synthetic resins. Hodogaya's core products include a wide range of chemical intermediates, pigments, and additives used in various industries, including automotive, electronics, and agriculture.
How the Company Makes MoneyHodogaya Chemical generates revenue through the sale of its chemical products to a diverse customer base across multiple industries. The company has a significant revenue stream from specialty chemicals, which are used in high-value applications, providing higher margins compared to commodity chemicals. Additionally, Hodogaya benefits from long-term partnerships with key clients in sectors like automotive and electronics, ensuring steady demand for its products. The company also invests in research and development to create innovative solutions and improve existing products, which helps maintain its competitive edge and drives revenue growth.

Hodogaya Chemical Co., Ltd. Financial Statement Overview

Summary
Financials are stable overall, supported by a strong balance sheet (low leverage; debt-to-equity ~0.19) and modest positive revenue growth (TTM +2.86%). The main drag is a clear step-down in profitability (TTM operating margin ~5.1%, net margin ~4.2%) and weak/volatile cash conversion with sharply lower TTM free cash flow (~¥0.55B).
Income Statement
63
Positive
Revenue growth has been modest but generally positive (TTM (Trailing-Twelve-Months) +2.86% following a stronger FY2025), indicating steady demand. Profitability is mixed: gross margin remains solid (~36–39%), but earnings power has compressed versus earlier years—TTM operating and net margins (~5.1% and ~4.2%) are notably below FY2022–FY2025 levels, suggesting cost pressure and/or weaker mix. Overall, the income statement reflects stability with a clear recent margin step-down as the main concern.
Balance Sheet
78
Positive
Leverage appears conservative with low debt relative to equity (debt-to-equity ~0.18–0.21 historically; 0.19 in TTM (Trailing-Twelve-Months)), providing balance-sheet flexibility for a specialty chemicals business. Equity has grown over time and assets have expanded, supporting financial resilience. The key weakness is profitability on equity trending lower (TTM ~3.8% vs ~5–8% in prior years), implying the capital base is strong but currently generating less return.
Cash Flow
42
Neutral
Cash generation is the most volatile area. While operating cash flow is positive in TTM (Trailing-Twelve-Months) (~¥6.1B), it covers a relatively small portion of earnings, and free cash flow is weak in TTM (Trailing-Twelve-Months) (~¥0.55B) with a sharp decline versus the prior year. The history shows meaningful swings (including negative free cash flow in FY2023 and strong free cash flow in FY2022/FY2024), indicating working-capital and/or investment-driven variability that reduces cash flow reliability.
BreakdownTTMMar 2025Mar 2024Mar 2023Mar 2022Mar 2021
Income Statement
Total Revenue45.79B48.58B44.26B43.32B41.88B41.20B
Gross Profit16.81B18.91B17.10B16.67B17.66B16.07B
EBITDA6.24B7.93B7.17B6.26B7.94B7.25B
Net Income2.29B3.18B2.48B2.22B3.25B3.12B
Balance Sheet
Total Assets87.48B79.86B81.16B72.05B66.45B62.61B
Cash, Cash Equivalents and Short-Term Investments11.66B10.77B12.96B10.49B11.45B9.45B
Total Debt9.46B8.90B9.81B11.08B7.02B8.19B
Total Liabilities23.81B21.32B23.71B22.16B18.54B18.96B
Stockholders Equity52.45B48.60B47.73B42.83B41.41B38.67B
Cash Flow
Free Cash Flow549.00M248.00M2.99B-2.06B4.38B3.07B
Operating Cash Flow6.12B5.67B8.34B1.06B6.14B5.38B
Investing Cash Flow-4.51B-6.55B-3.95B-7.04B-3.57B-2.69B
Financing Cash Flow-685.00M-1.88B-2.07B2.29B-1.85B-424.00M

Hodogaya Chemical Co., Ltd. Technical Analysis

Technical Analysis Sentiment
Positive
Last Price1877.00
Price Trends
50DMA
2293.24
Positive
100DMA
2065.08
Positive
200DMA
1794.25
Positive
Market Momentum
MACD
26.48
Positive
RSI
58.42
Neutral
STOCH
61.62
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For JP:4112, the sentiment is Positive. The current price of 1877 is below the 20-day moving average (MA) of 2346.75, below the 50-day MA of 2293.24, and above the 200-day MA of 1794.25, indicating a bullish trend. The MACD of 26.48 indicates Positive momentum. The RSI at 58.42 is Neutral, neither overbought nor oversold. The STOCH value of 61.62 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for JP:4112.

Hodogaya Chemical Co., Ltd. Peers Comparison

Overall Rating
UnderperformOutperform
Sector (61)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
78
Outperform
¥42.03B15.651.90%2.15%16.14%
75
Outperform
¥62.08B13.672.92%3.03%28.27%
74
Outperform
¥38.97B26.793.24%1.83%-8.54%
74
Outperform
¥42.32B5.503.70%14.83%51.42%
70
Outperform
¥65.80B15.824.37%-1.09%
67
Neutral
¥39.05B16.632.37%-11.70%-54.82%
61
Neutral
$10.43B7.12-0.05%2.87%2.86%-36.73%
* Basic Materials Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
JP:4112
Hodogaya Chemical Co., Ltd.
2,391.00
866.59
56.85%
JP:4027
Tayca Corporation
1,823.00
363.82
24.93%
JP:4078
Sakai Chemical Industry Co., Ltd.
4,150.00
1,528.17
58.29%
JP:4362
Nippon Fine Chemical Co., Ltd.
2,797.00
709.72
34.00%
JP:4462
Ishihara Chemical Company,Ltd.
2,896.00
740.74
34.37%
JP:4611
Dai Nippon Toryo Company, Limited
1,494.00
305.30
25.68%

Hodogaya Chemical Co., Ltd. Corporate Events

Hodogaya Chemical Unveils FY2025 Third-Quarter Consolidated Results Overview
Feb 13, 2026

Hodogaya Chemical Co., Ltd. released its consolidated financial results presentation for the third quarter of fiscal year 2025, which ends in March 2026. The materials outline an overview of group performance, segment-by-segment results, and reference indicators such as net sales, operating profit, and EBITDA, signaling continued emphasis on transparency around earnings quality and segment contributions for investors and other stakeholders.

The most recent analyst rating on (JP:4112) stock is a Hold with a Yen2673.00 price target. To see the full list of analyst forecasts on Hodogaya Chemical Co., Ltd. stock, see the JP:4112 Stock Forecast page.

Hodogaya Chemical Profit Slumps as Company Sticks to Weaker Full-Year Outlook
Feb 13, 2026

Hodogaya Chemical reported consolidated net sales of ¥34.45 billion for the nine months to December 31, 2025, down 7.5% year on year, with operating profit plunging 47.1% to ¥2.43 billion and profit attributable to owners of parent falling 30.9% to ¥1.99 billion. Despite weaker earnings and a lower equity-to-asset ratio of 60.0%, comprehensive income nearly doubled, and the company maintained its full-year forecast, signaling confidence while forecasting a 3.2% revenue decline and a roughly 28% drop in operating profit for the year to March 31, 2026.

The company plans an annual dividend of ¥50 per share for the fiscal year ending March 31, 2026 on a post-split basis, compared with an effective ¥90 per share in the prior year before a 2-for-1 stock split, pointing to a reduced shareholder payout. Hodogaya also reported an increase in total assets and net assets, minor changes in treasury share levels, and the exclusion of one subsidiary from its consolidation scope, moves that may subtly reshape its balance sheet and group structure without altering its earnings guidance.

The most recent analyst rating on (JP:4112) stock is a Hold with a Yen2673.00 price target. To see the full list of analyst forecasts on Hodogaya Chemical Co., Ltd. stock, see the JP:4112 Stock Forecast page.

Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Feb 18, 2026